Search results
Psychedelic drug MDMA faces questions as FDA considers approval for PTSD
WPRI Providence· 3 days agoWASHINGTON (AP) — Federal health regulators are questioning the safety and evidence behind the first...
FDA approves Moderna’s RSV vaccine mRESVIA
Pharmaceutical Technology via Yahoo Finance· 8 hours agoModerna has secured approval from the US Food and Drug Administration (FDA) for its mRNA-based respiratory syncytial virus (RSV) vaccine mRESVIA...
Psychoactive drugs are having a moment. The FDA will soon weigh in
The State· 8 hours agoPsychoactive drugs are having a moment. Investors are piling into the nascent field, and a host of medications based on MDMA, LSD, psychedelic mushrooms, ketamine, the South American plant mixture ...
Lack of insurance keeps many Americans from best cancer meds
Medical Xpress· 2 hours agoNew policies are needed "to improve health insurance coverage options and to make new treatments...
Liquidia Stock Surges After Winning Patent Battle Vs. United Therapeutics
Investor's Business Daily· 2 hours agoYutrepia is an inhaled version of treprostinil. Liquidia sells treprostinil in pills, powder and...
European Commission grants marketing approval to Biogen's ALS drug
Reuters via AOL· 4 days agoThe approval is based on a 108-patient trial that showed Qalsody reduced levels of a neurofilament...
Pentagon's 'barbaric' drug testing on beagles raises hackles of pet-loving politicians
Fox News· 8 hours agoPet lovers in Congress are outraged over a new discovery that the Pentagon is reportedly funding...
The Download: MDMA for PTSD, and Boeing’s rearranged space flight
Technology Review· 9 hours agoMDMA has been banned in the United States for more than three decades. On June 4, the Food and Drug...
Disruption or integration – consumer electronics as medical devices
Medical Device Network via Yahoo Finance· 9 hours agoThe successful approval of atrial fibrillation detection on the Apple Watch by the US Food and Drug...
Gilead drug fails to confirm its FDA approval in bladder cancer - Silicon Valley Business Journal
The Business Journals· 3 days agoA drug at the center of a $21 billion acquisition by Gilead Sciences Inc. four years ago failed a...